| Company/Division name | One Biosciences |
| Parent company | One Biosciences |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 42 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2026 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | France |
| City reshored to: | Albany |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Computer & Electronic Products |
| Product(s) reshored | cancer diagnostic technology |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Government Incentives, Impact on domestic economy, Skilled workforce availability/training |
| Government Incentive dollar amount: | 525,000 |
